NU SKIN ENTERPRISES, INC.(NUS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,286 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NUS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for NU SKIN ENTERPRISES, INC. (NUS), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores NUS at 53.4/100 on a 32-signal composite quality model, placing it at rank #1,286 of 2,879 stocks — the top half of the AI-ranked universe. NUS scores in the top quartile across earnings quality (99.8), balance sheet strength (87.7), profitability (77.4). Areas of concern include revenue growth (10.2) and institutional flow (24.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), NU SKIN ENTERPRISES, INC. reports quarterly revenue of $320.6M, net income of $1.8M, free cash flow of $-17.6M. Top institutional holders of NUS by reported 13-F value include BlackRock,, CHARLES SCHWAB INVESTMENT MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NUS trades on the NYSE exchange and files with the SEC under CIK 1021561. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NUS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NU SKIN ENTERPRISES, INC. directly from SEC EDGAR. NU SKIN ENTERPRISES, INC.'s 13F Pro composite quality score has ranged between 8 and 58 since 2021, currently 53.4 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$320.6M
Net Income
Q1 2026
$1.8M
Free Cash Flow
Q1 2026
$-17.6M
D/E Ratio
Q1 2026
0.28
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-14.3% YoYNet Income
+209.3% YoYOperating Income
+143.4% YoYEPS (Diluted)
+207.8% YoYTotal Assets
-4.3% YoYTotal Debt
-43.0% YoYOp. Cash Flow
-28.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.49B -14.3% | $1.73B -12.0% | $1.97B -11.5% | $2.23B -17.4% | $2.70B +4.4% | $2.58B |
| Net Income | $160.2M +209.3% | $-146.6M -1805.6% | $8.6M -91.8% | $104.8M -28.9% | $147.3M -23.0% | $191.4M |
| Operating Income | $65.8M +143.4% | $-151.6M -414.0% | $48.3M -56.5% | $110.8M -52.6% | $234.0M -9.2% | $257.6M |
| EPS (Diluted) | $3.18 +207.8% | $-2.95 -1835.3% | $0.17 -91.8% | $2.07 -27.6% | $2.86 -21.2% | $3.63 |
| Total Assets | $1.41B -4.3% | $1.47B -18.7% | $1.81B -0.8% | $1.82B -4.5% | $1.91B -2.6% | $1.96B |
| Total Debt | $224.2M -43.0% | $393.6M -21.8% | $503.0M +25.0% | $402.5M +7.0% | $376.3M +12.2% | $335.4M |
| Operating Cash Flow | $80.3M -28.2% | $111.7M -5.8% | $118.6M +9.8% | $108.1M -23.7% | $141.6M -62.7% | $379.1M |
AI Insight: NUS Financial Trends
Debt cut nearly in half since Q2 2024, but revenue has declined six consecutive quarters to a multi-period low of $321M in Q1 2026.
• Total debt fell sharply from $458M in Q2 2024 to $224M in Q1 2026, a 51% reduction over seven quarters.
• Equity has gradually strengthened from $686M in Q2 2024 to $805M in Q4 2025, though it dipped to $794M in Q1 2026.
• Revenue has declined from $446M in Q4 2024 to $321M in Q1 2026, the lowest level in the dataset.
• Operating income turned positive in Q2 2025 ($31M) after three quarters of losses, but compressed to just $4M in Q1 2026.
⚠ Operating cash flow turned negative at -$4M in Q1 2026, the first negative reading in the dataset — a key deterioration signal.
⚠ Q1 2025 net income of $108M appears anomalous versus surrounding quarters; likely driven by a non-recurring item, not operating momentum.
⚠ Revenue contraction accelerating — Q1 2026 at $321M is 17% below Q2 2024; stabilization needed to validate balance-sheet progress.
AI Insight: NUS Ratio Trends
Nu Skin has stabilized after catastrophic losses in Q2 and Q4 2024, but Q1 2026 profitability collapsed to near-zero, raising doubts about sustainability.
• Operating margin swung from -28.6% in Q2 2024 to a recovery range of 5.9%–8.0% across Q3 2025–Q2 2025, then fell sharply to 1.3% in Q1 2026.
• Leverage improved materially: D/E declined from 0.67 in Q2 2024 to 0.28 by Q4 2025 and held at 0.28 in Q1 2026.
• ROIC turned positive and reached 11.9% in Q2 2025 but has decelerated steadily to 1.6% in Q1 2026.
⚠ Q1 2026 NPM dropped to 0.6% from 3.9% in Q4 2025 — monitor whether this reflects seasonal weakness or renewed structural deterioration.
⚠ Recurring large negative quarters (Q2 2024, Q4 2024) suggest potential for impairment or restructuring charges; watch Q2 2026 closely.
Get alerted when NUS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NU SKIN ENTERPRISES, INC. including:
Top Institutional Holders of NUS
BlackRock, Inc.
$31.2M4,291,263 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$15.6M2,143,294 shVANGUARD CAPITAL MANAGEMENT LLC
$15.0M2,063,350 shAMERICAN CENTURY COMPANIES INC
$14.7M2,021,202 shPRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
$13.1M1,794,608 shDIMENSIONAL FUND ADVISORS LP
$12.6M1,735,182 shVANGUARD PORTFOLIO MANAGEMENT LLC
$12.4M1,709,553 shRENAISSANCE TECHNOLOGIES LLC
$12.4M1,700,496 shAQR CAPITAL MANAGEMENT LLC
$8.9M1,236,338 shGEODE CAPITAL MANAGEMENT, LLC
$8.7M1,188,166 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $31.2M | 4,291,263 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.6M | 2,143,294 |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.0M | 2,063,350 |
| AMERICAN CENTURY COMPANIES INC | $14.7M | 2,021,202 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | $13.1M | 1,794,608 |
| DIMENSIONAL FUND ADVISORS LP | $12.6M | 1,735,182 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.4M | 1,709,553 |
| RENAISSANCE TECHNOLOGIES LLC | $12.4M | 1,700,496 |
| AQR CAPITAL MANAGEMENT LLC | $8.9M | 1,236,338 |
| GEODE CAPITAL MANAGEMENT, LLC | $8.7M | 1,188,166 |
More Consumer Staples Companies
View all Consumer Staples →Put NUS on your watchlist
Track score changes the day NU SKIN ENTERPRISES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NUS a good stock to buy?
13F Pro's AI-powered analysis of NU SKIN ENTERPRISES, INC. (NUS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NUS are available on the NUS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own NUS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NUS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NU SKIN ENTERPRISES, INC.'s investment landscape.